Technology News and Research

RSS

Discovery of a key marker in breast cancer tumors

Cancer researchers at Georgetown University Medical Center have discovered a key marker in breast cancer tumors that may help determine which women with early stage breast cancer have a better chance of survival. The research appears in the June 1 issue of the Journal of Clinical Oncology.

31 May 2004

Greater the time spent in cars, higher the likelihood of obesity

A comprehensive study done by the Georgia Institute of Technology shows the built environment clearly relates to a person’s prospects for being overweight. Every additional 30 minutes a person spends in a car translates into a 3 percent greater chance of being obese.

31 May 2004

Smoking a lot more harmful than previously thought

The U.S. Surgeon General has released a new comprehensive report on smoking and health, revealing for the first time that smoking causes diseases in nearly every organ of the body. Published 40 years after the surgeon general's first report on smoking -- which concluded that smoking was a definite cause of three serious diseases -- this newest report finds that cigarette smoking is conclusively linked to diseases such as leukemia, cataracts, pneumonia and cancers of the cervix, kidney, pancreas and stomach.

30 May 2004

3-D micro-imaging technology licensed to Carl Zeiss Jena by Cornell

Biomedical microscopic imaging deep inside living tissue with unprecedented clarity could become routine and widely available with the signing of technology-transfer and collaborative-research agreements today (May 28, 2004) by Carl Zeiss Jena GmbH, a leading maker of microscopy instrumentation, and by CCTEC, the technology, enterprise and commercialization arm of Cornell University.

30 May 2004

First-of-its-kind wearable low vision aid helps visually impaired

"Even with a cane or a guide dog, low-vision people can have a difficult time identifying obstacles that can be hazardous," said Eric Seibel, research assistant professor in mechanical engineering at the lab, who for the past four years has overseen the student team that developed the device. "This is another set of eyes looking out for them."

27 May 2004

Randomness in gene expression to lead to differences in people that are genetically identical

Experiments by Howard Hughes Medical Institute (HHMI) researchers have revealed it might be possible for randomness in gene expression to lead to differences in cells — or people, for that matter — that are genetically identical.

27 May 2004

Smoking causes diseases in nearly every organ of the body

U.S. Surgeon General Richard H. Carmona today released a new comprehensive report on smoking and health, revealing for the first time that smoking causes diseases in nearly every organ of the body.

27 May 2004

Australian cricketers have had their muscles scanned by researchers to prevent muscle deterioration and injury

The 24-man-squad from Cricket Australia’s Centre of Excellence in Brisbane, were examined by University of Queensland’s senior physiotherapy lecturer Dr Julie Hides.

27 May 2004

New study challenges current thinking about varied response to hepatitis C treatment in different racial groups

Results of a new study published in the current issue of the New England Journal of Medicine show that in patients who have chronic hepatitis C, genotype 1 -- the most common form of the disease and difficult to treat successfully -- non-Hispanic whites achieved one of the highest response rates reported to date, but response rates in African Americans were significantly lower.

27 May 2004

New technology gives neurosurgeons real-time images in the operating room

Within the past decade, imaging systems have provided much clearer pictures of the brain’s structures, and navigational tools have helped physicians map direct approaches, minimize points of entry and spare healthy brain and function.

27 May 2004

Human Genome Sciences has begun dosing patients with chronic hep C drug

Human Genome Sciences, Inc. announced today that it has begun dosing patients in a Phase 2 clinical trial of Albuferon™ (albumin-interferon alpha) in patients with chronic hepatitis C who are naïve to interferon-alpha treatments.

27 May 2004

Good evidence that genes play an important role in causing schizophrenia

There is good evidence that genes play an important role in causing schizophrenia. The disease prevalence is higher among blood relatives than non-related people and males are affected more frequently than females.

26 May 2004

New technology to measure the sensitivity of nerve fibers that wire up the brain during development

Researchers at Georgetown University have developed a novel technology to precisely measure the sensitivity of nerve fibers that wire up the brain during development. Through use of this technology, they discovered that these fibers, or axons, possess an incredible sensitivity to molecular guidance cues that direct the axon’s route to its desired destination in the brain.

26 May 2004

New company is developing advanced therapeutics for stroke victims

Arizona Engineered Therapeutics Inc., a new company based on the research of three Arizona State University professors, is moving its first drug candidate closer to clinical trials.

26 May 2004

Results from a clinical study of CyberKnife ® radiosurgery for locally advanced pancreatic cancer

Accuray Incorporated announced today the publication of the results from a clinical study of CyberKnife ® radiosurgery for locally advanced pancreatic cancer.

25 May 2004

Focus on implantation of artificial discs to treat degenerative disc disease

Implantation of artificial discs to treat degenerative disc disease was the subject of multiple presentations earlier this month at the Spine Arthroplasty Meeting in Vienna, Austria, where spine and orthopaedic surgeons from all over the world heard new data about this technology.

25 May 2004

Zengen announces positive results of treatment for vaginal yeast infection

Zengen Inc. announced today positive phase I/II results for its proprietary molecule CZEN-002 for the treatment of vulvovaginal candidiasis (VVC), commonly known as vaginal yeast infection.

25 May 2004

£1.8m Unit for treating teenagers with cancer at University Hospital of Wales

A Welsh donor has already given a massive £650,000 and Teenage Cancer Trust has pledged £650,000 from its central funds. On Monday 24th May, Teenage Cancer Trust will launch its fundraising campaign for the Unit at St David’s Hotel, Cardiff Bay. The charity is looking to raise a minimum of £500,000 to reach their target.

25 May 2004

QRS Diagnostic gets patent approval for computer-card medical device technology

QRS Diagnostic, leader in innovative design and development of software-based medical devices, announces that the United States Patent and Trademark Office approved a new patent on its design of medical devices contained in computer cards

25 May 2004

Possible new second-generation multiple sclerosis therapy

Scientists from Genencor International, Inc., have demonstrated in an in vivo model that a new variant of recombinant interferon-beta reduces the immunological response to the protein.

25 May 2004